CX3CL1 and hepatocellular carcinoma: In addition, inhibition of CacyBP-Myd88 axis impaired the recruitment of TAMs into the TME by reducing CX3CL1 secretion and sensitized HCC-bearing mice to anti-PD-1 therapy.